Unknown

Dataset Information

A study of the dopamine transporter using the TRACT assay, a novel in vitro tool for solute carrier drug discovery.


ABSTRACT: Members of the solute carrier (SLC) transporter protein family are increasingly recognized as therapeutic drug targets. The majority of drug screening assays for SLCs are based on the uptake of radiolabeled or fluorescent substrates. Thus, these approaches often have limitations that compromise on throughput or the physiological environment of the SLC. In this study, we report a novel application of an impedance-based biosensor, xCELLigence, to investigate dopamine transporter (DAT) activity via substrate-induced activation of G protein-coupled receptors (GPCRs). The resulting assay, which is coined the 'transporter activity through receptor activation' (TRACT) assay, is based on the hypothesis that DAT-mediated removal of extracellular dopamine directly affects the ability of dopamine to

SUBMITTER: Sijben HJ 

PROVIDER: S-EPMC7809260 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature